Sign in

    James Charles Goss

    Research Analyst at Barrington Research Associates, Inc.

    James Charles Goss is Managing Director and Senior Research Analyst at Barrington Research Associates, specializing in media and entertainment equity research, including content & distribution, digital media, and theatrical exhibition. He covers companies such as Regencell among others, drawing on a record of industry recognition, including four-time accolades in The Wall Street Journal’s 'Best on the Street' analyst survey. Goss began his analyst career at Duff & Phelps in 1972, focused on retail, oil services, and media, then served at Nesbitt Burns Securities before joining Barrington in 1998. He holds the Chartered Financial Analyst (CFA) designation, an MBA in Finance and Accountancy from the University of Illinois at Urbana-Champaign, and an honors BA in Mathematics from Lewis University.

    James Charles Goss's questions to Regencell Bioscience Holdings (RGC) leadership

    James Charles Goss's questions to Regencell Bioscience Holdings (RGC) leadership • Q2 2016

    Question

    James Charles Goss of Barrington Research Associates, Inc. asked about capacity utilization in reseated theatres, reseating opportunities in smaller markets, and whether the ability to reseat proprietary RPX screens makes them more attractive than IMAX screens.

    Answer

    Executive VP, CFO & Treasurer David H. Ownby confirmed anecdotally that sold-out recliner screens are shifting customer traffic to off-peak times, which is a positive trend. Chairman & CEO Amy E. Miles noted that while they have more flexibility with their own RPX screens and see 'promising results' from reseating them, discussions with IMAX about their auditoriums are ongoing.

    Ask Fintool Equity Research AI